174 related articles for article (PubMed ID: 12208936)
21. Thermodynamic studies on hairpin forming antisense-oligodeoxynucleotides directed against hepatitis C virus RNA.
Lehmann TJ; Eisenhardt S; Engels JW
Nucleosides Nucleotides; 1999; 18(6-7):1689-91. PubMed ID: 10474247
[TBL] [Abstract][Full Text] [Related]
22. Targeting Highly Structured RNA by Cooperative Action of siRNAs and Helper Antisense Oligomers in Living Cells.
Dutkiewicz M; Ojdowska A; Kuczynski J; Lindig V; Zeichhardt H; Kurreck J; Ciesiołka J
PLoS One; 2015; 10(8):e0136395. PubMed ID: 26308932
[TBL] [Abstract][Full Text] [Related]
23. Virological effects of ISIS 14803, an antisense oligonucleotide inhibitor of hepatitis C virus (HCV) internal ribosome entry site (IRES), on HCV IRES in chronic hepatitis C patients and examination of the potential role of primary and secondary HCV resistance in the outcome of treatment.
Soler M; McHutchison JG; Kwoh TJ; Dorr FA; Pawlotsky JM
Antivir Ther; 2004 Dec; 9(6):953-68. PubMed ID: 15651754
[TBL] [Abstract][Full Text] [Related]
24. Secondary structure determination of the conserved 98-base sequence at the 3' terminus of hepatitis C virus genome RNA.
Blight KJ; Rice CM
J Virol; 1997 Oct; 71(10):7345-52. PubMed ID: 9311812
[TBL] [Abstract][Full Text] [Related]
25. Secondary structure of the 5' nontranslated regions of hepatitis C virus and pestivirus genomic RNAs.
Brown EA; Zhang H; Ping LH; Lemon SM
Nucleic Acids Res; 1992 Oct; 20(19):5041-5. PubMed ID: 1329037
[TBL] [Abstract][Full Text] [Related]
26. Conjugation of an antisense oligodeoxynucleotide to ribonuclease h results in sequence-specific cleavage and intracellular inhibition of HCV gene expression.
Fukuma T; Walton CM; Wu CH; Wu GY
Bioconjug Chem; 2003; 14(2):295-301. PubMed ID: 12643739
[TBL] [Abstract][Full Text] [Related]
27. Hepatitis C virus in lymphoid cells of patients coinfected with human immunodeficiency virus type 1: evidence of active replication in monocytes/macrophages and lymphocytes.
Laskus T; Radkowski M; Piasek A; Nowicki M; Horban A; Cianciara J; Rakela J
J Infect Dis; 2000 Feb; 181(2):442-8. PubMed ID: 10669324
[TBL] [Abstract][Full Text] [Related]
28. cis-Acting RNA elements in the hepatitis C virus RNA genome.
Sagan SM; Chahal J; Sarnow P
Virus Res; 2015 Aug; 206():90-8. PubMed ID: 25576644
[TBL] [Abstract][Full Text] [Related]
29. RNA Interference-Guided Targeting of Hepatitis C Virus Replication with Antisense Locked Nucleic Acid-Based Oligonucleotides Containing 8-oxo-dG Modifications.
Mutso M; Nikonov A; Pihlak A; Žusinaite E; Viru L; Selyutina A; Reintamm T; Kelve M; Saarma M; Karelson M; Merits A
PLoS One; 2015; 10(6):e0128686. PubMed ID: 26039055
[TBL] [Abstract][Full Text] [Related]
30. Phosphorothioate antisense oligodeoxynucleotides capable of inhibiting hepatitis C virus gene expression: in vitro translation assay.
Seki M; Honda Y
J Biochem; 1995 Dec; 118(6):1199-204. PubMed ID: 8720135
[TBL] [Abstract][Full Text] [Related]
31. Isolation and characterization of RNA aptamers specific for the HCV minus-IRES domain I.
Konno K; Fujita S; Iizuka M; Nishikawa S; Hasegawa T; Fukuda K
Nucleic Acids Symp Ser (Oxf); 2008; (52):493-4. PubMed ID: 18776469
[TBL] [Abstract][Full Text] [Related]
32. Hepatitis C IRES: translating translation into a therapeutic target.
Jubin R
Curr Opin Mol Ther; 2001 Jun; 3(3):278-87. PubMed ID: 11497352
[TBL] [Abstract][Full Text] [Related]
33. Characterizing the function and structural organization of the 5' tRNA-like motif within the hepatitis C virus quasispecies.
Piron M; Beguiristain N; Nadal A; Martínez-Salas E; Gómez J
Nucleic Acids Res; 2005; 33(5):1487-502. PubMed ID: 15755750
[TBL] [Abstract][Full Text] [Related]
34. The 5'-terminal region of the Aichi virus genome encodes cis-acting replication elements required for positive- and negative-strand RNA synthesis.
Nagashima S; Sasaki J; Taniguchi K
J Virol; 2005 Jun; 79(11):6918-31. PubMed ID: 15890931
[TBL] [Abstract][Full Text] [Related]
35. Genetic analysis of sequences in the 3' nontranslated region of hepatitis C virus that are important for RNA replication.
Friebe P; Bartenschlager R
J Virol; 2002 Jun; 76(11):5326-38. PubMed ID: 11991961
[TBL] [Abstract][Full Text] [Related]
36. Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides.
Brown-Driver V; Eto T; Lesnik E; Anderson KP; Hanecak RC
Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):145-54. PubMed ID: 10355821
[TBL] [Abstract][Full Text] [Related]
37. Specific inhibition of hepatitis C virus expression by antisense oligodeoxynucleotides. In vitro model for selection of target sequence.
Wakita T; Wands JR
J Biol Chem; 1994 May; 269(19):14205-10. PubMed ID: 8188703
[TBL] [Abstract][Full Text] [Related]
38. Analysis of hepatitis C virus RNA dimerization and core-RNA interactions.
Ivanyi-Nagy R; Kanevsky I; Gabus C; Lavergne JP; Ficheux D; Penin F; Fossé P; Darlix JL
Nucleic Acids Res; 2006; 34(9):2618-33. PubMed ID: 16707664
[TBL] [Abstract][Full Text] [Related]
39. Thermodynamic and phylogenetic prediction of RNA secondary structures in the coding region of hepatitis C virus.
Tuplin A; Wood J; Evans DJ; Patel AH; Simmonds P
RNA; 2002 Jun; 8(6):824-41. PubMed ID: 12088154
[TBL] [Abstract][Full Text] [Related]
40. A novel sequence found at the 3' terminus of hepatitis C virus genome.
Tanaka T; Kato N; Cho MJ; Shimotohno K
Biochem Biophys Res Commun; 1995 Oct; 215(2):744-9. PubMed ID: 7488017
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
